Human recombinant apolipoprotein E-enriched liposomes can mimic low- density lipoproteins as carriers for the site-specific delivery of antitumor agents

Molecular Pharmacology

Volumn 52, Issue 3, 1997, Pages 445-465

  Rensen, Patrick C N ^a   Schiffelers, Raymond M ^a   Versluis, A Jenny ^a   Bijsterbosch, Martin K ^a   Van Kuijk Meuwissen, Marly E M J ^a   Van Berkel, Theo J C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E; CHOLESTEROL OLEATE; DRUG CARRIER; HUMAN RECOMBINANT APOLIPOPROTEIN E; LIPOSOME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG UPTAKE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT;

EID: 0030851111     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.3.445     Document Type: Article

References (40)

1. Rose, G., and M. J. Shipley. Plasma lipids and mortality: a source of error. Lancet 1:523-526 (1980).
2. Markel, A., and G. J. Brook. Cancer and hypocholesterolemia. Isr. J. Med. Sci. 30:787-793 (1994).
3. Firestone, R. A. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjugate Chem. 5:105-113 (1994).
4. Pekkanen, J., A. Nissinen, E. Vartiainen, J. T. Salonen, S. Punsar, and M. J. Karvonen. Changes in serum cholesterol level and mortality: a 30-year follow-up: the Finnish Cohorts of the Seven Countries Study. Am. J. Epidemiol. 139:155-165 (1994).
5. Iribarren, C., D. M. Reed, R. Chen, K. Yano, and J. H. Dwyer. Low serum cholesterol and mortality: which is the cause and which is the effect? Circulation 92:2396-2403 (1995).
6. Niendorf, A., H. Nägele, D. Gerding, U. Meyer-Pannwitt, and A. Gebhardt. Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery. Int. J. Cancer 61:461-464 (1995).
7. Brown, M. S., and J. L. Goldstein. A receptor-mediated pathway for cholesterol homeostasis. Science (Washington D. C.) 232:34-47 (1986).
8. Goldstein, J. L., A. S. Helgeson, M. S., and Brown. Inhibition of cholesterol synthesis with compactin renders growth of human cultured cells dependent on the low density lipoprotein receptor. J. Biol. Chem. 254:5403-5409 (1979).
9. De Smidt, P. C., and Th. J. C. Van Berkel. LDL-mediated drug targeting. Crit. Rev. Ther. Drug Carrier Syst. 77:99-120 (1990).
10. Masquelier, M., S. Vitols, and C. Peterson. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. Cancer Res. 46:3842-3847 (1986).
11. Vitols, S., B. Angelin, S. Ericsson, G. Gahrton, G. Juliusson, M. Masquelier, C. Paul, C. Peterson, M. Rudling, K. Söderberg-Reid, and U. Tidefelt. Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc. Natl. Acad. Sci. USA 87:2598-2602 (1990).
12. Ginsburg, G. S., D. M. Small, and D. Atkinson. Microemulsions of phospholipids and cholesteryl esters: protein-free models of low density lipoprotein. J. Biol. Chem. 257:8216-8227 (1982).
13. Lundberg, B., K. Hong, and D. Papahadjopoulos. Conjugation of apolipoprotein B with liposomes and targeting to cells in culture. Biochim. Biophys. Acta 1149:305-312 (1993).
14. Ginsburg, G. S., M. T. Walsh, D. M. Small, and D. Atkinson. Reassembled plasma low density lipoproteins: phospholipid-cholesterol ester-apoprotein B complexes. J. Biol. Chem. 259:6667-6673 (1984).
15. Lundberg, B., and L. Suominen. Preparation of biologically active analogs of serum low density lipoprotein. J. Lipid Res. 25:550-558 (1984).
16. Galeano, N. F., R. Milne, Y. L. Marcel, M. T. Walsh, E. Levy, T. D. Ngu'yen, A. Gleeson, Y. Arad, L. Witte, M. Al-Haideri, S. C. Rumsey, and R. J. Deckelbaum. Apoprotein structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 269:511-519 (1994).
17. Wilson, C. M. R. Wardell, K. H. Weisgraber, R. W. Mahley, and D. A. Agard. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science (Washington D. C.) 252:1817-1822 (1991).
18. Innerarity, T. L., R. E. Pitas, and R. W. Mahley. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254:4186-4190 (1979).
19. c. Proc. Natl. Acad. Sci. USA 76:2311-2315 (1979).
20. Rensen, P. C. N., N. Herijgers, M. H. Netscher, S. C. J. Meskers, M. van Eck, and Th. J. C. van Berkel. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38:1070-1084 (1997).
21. Vogel, T., K. H. Weisgraber, M. I. Zeevi, H. B. Ben-Artzi, A. Z. Levanon, S. C. Rall Jr., T. L. Innerarity, D. Y. Hui, J. M. Taylor, D. Kanner, Z. Yavin, B. Amit, H. Aviv, M. Gorecki, and R. W. Mahley. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc. Natl. Acad. Sci. USA 82:8696-8700 (1985).
22. Redgrave, T. G., D. C. K. Roberts, and C. E. West. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49 (1975).
23. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
24. McFarlane, A. S. Efficient trace-labelling of proteins with iodine. Nature (Lond.) 182:53-58 (1958).
25. Rensen, P. C. N., and Th. J. C. Van Berkel. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich emulsions in vitro and in vivo. J. Biol. Chem. 271:14791-14799 (1996).
26. Tajima, S., S. Yokoyama, and A. Yamamoto. Effect of lipid particle size on association of apolipoproteins with lipid. J. Biol. Chem. 258:10073-10082 (1983).
27. Bligh, E. G., and W. J. Dyer. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917 (1959).
28. Rensen, P. C. N., M. C. M. Van Dijk, E. C. Havenaar, M. K. Bijsterbosch, J. K. Kruijt, and Th. J. C. Van Berkel. Selective targeting of antivirals by recombinant chylomicrons: a new therapeutic approach to hepatitis B. Nat. Med. 1:221-225 (1995).
29. Chao, Y. S., E. E. Windler, G. C. Chen, and R. J. Havel. Hepatic catabolism of rat and human lipoproteins in rats treated with 17α-ethinyl estradiol. J. Biol. Chem. 254:11360-11366 (1979).
30. De Duve, C., B. C. Pressman, R. Gianetto, R. Wattiaux, and F. Appelmans. Tissue fractionation studies: 6. Intracellular distribution patterns of enzymes in rat liver tissue. Biochem. J. 60:604-617 (1955).
31. Patel, H. M. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Syst. 9:39-90 (1992).
32. New, R. R. C. Liposomes: A Practical Approach. IRL Press, Oxford (1990).
33. Nagelkerke, J. F., H. F. Bakkeren, K. Kuipers, R. J. Vonk, and Th. J. C. Van Berkel. Hepatic processing of the cholesteryl esters from low density lipoprotein in the rat. J. Biol. Chem. 261:8909-8913 (1986).
34. Bertolotti, M., and D. K. Spady. Effect of hypocholesterolemic doses of 17α-ethinyl estradiol on cholesterol balance in liver and extrahepatic tissues. J. Lipid Res. 37:1812-1822 (1996).
35. Van Berkel, Th. J. C., J. K. Kruijt, and H. M. Kempen. Specific targeting of high density lipoproteins to liver hepatocytes by incorporation of a tris-galactoside-terminated cholesterol derivative. J. Biol. Chem. 260: 12203-12207 (1985).
36. Versluis, A. J., P. J. Van Geel, H. Oppelaar, T. J. C. Van Berkel, and M. K. Bijsterbosch. Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice. Br. J. Cancer 74:525-532 (1996).
37. 14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein: partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim. Biophys. Acta 712:444-452 (1982).
38. Pieters, M. N., D. Schouten, H. F. Bakkeren, B. Esbach, A. Brouwer, D. L. Knook, and Th. J. C. Van Berkel. Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat liver parenchymal cells in vivo is efficiently coupled to bile acid synthesis. Biochem. J. 280:359-365 (1991).
39. Dietschy, J. M., S. D. Turley, and D. K. Spady. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34:1637-1659 (1993).
40. De Smidt, P. C., T. Le Doan, S. De Falco, and Th. J. C. Van Berkel. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res. 19:4695-1700 (1991).